Swiss National Bank’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,853
Closed -$1.12M 2587
2023
Q3
$1.12M Buy
6,853
+426
+7% +$101K ﹤0.01% 2181
2023
Q2
$2.11M Buy
6,427
+520
+9% +$159K ﹤0.01% 1851
2023
Q1
$1.63M Sell
5,907
-660
-10% -$242K ﹤0.01% 1961
2022
Q4
$2.54M Buy
6,567
+147
+2% +$41.5K ﹤0.01% 1752
2022
Q3
$1.53M Buy
6,420
+113
+2% +$30.3K ﹤0.01% 2059
2022
Q2
$1.41M Hold
6,307
﹤0.01% 2159
2022
Q1
$4.29M Buy
6,307
+547
+9% +$329K ﹤0.01% 1545
2021
Q4
$3.98M Hold
5,760
﹤0.01% 1614
2021
Q3
$4.27M Buy
5,760
+47
+0.8% +$32K ﹤0.01% 1574
2021
Q2
$4.28M Buy
+5,713
New +$4.37M ﹤0.01% 1603

Other funds holding OM

Swiss National Bank's OM Position: Q4 2023 in Review

Swiss National Bank sold out of Outset Medical (OM) in Q4 2023, closing a stake of 6,853 shares — an estimated $1.12M sold.

Swiss National Bank first reported a position in OM in Q2 2021 and held it in 10 quarters. The position peaked at $4.29M in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Swiss National Bank reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 6,853 Outset Medical shares in Q4 2023, an estimated $1.12M.
  • Swiss National Bank first reported a position in Outset Medical in Q2 2021 and held it in 10 quarters.
  • Swiss National Bank's Outset Medical position peaked at $4.29M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.